NO2820418T3 - - Google Patents

Info

Publication number
NO2820418T3
NO2820418T3 NO13745268A NO13745268A NO2820418T3 NO 2820418 T3 NO2820418 T3 NO 2820418T3 NO 13745268 A NO13745268 A NO 13745268A NO 13745268 A NO13745268 A NO 13745268A NO 2820418 T3 NO2820418 T3 NO 2820418T3
Authority
NO
Norway
Application number
NO13745268A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2820418T3 publication Critical patent/NO2820418T3/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79Transferrins, e.g. lactoferrins, ovotransferrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/20Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/60Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO13745268A 2011-08-17 2013-07-22 NO2820418T3 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161524508P 2011-08-17 2011-08-17

Publications (1)

Publication Number Publication Date
NO2820418T3 true NO2820418T3 (cg-RX-API-DMAC7.html) 2018-05-05

Family

ID=47715692

Family Applications (1)

Application Number Title Priority Date Filing Date
NO13745268A NO2820418T3 (cg-RX-API-DMAC7.html) 2011-08-17 2013-07-22

Country Status (15)

Country Link
US (1) US9290562B2 (cg-RX-API-DMAC7.html)
EP (1) EP2744831B1 (cg-RX-API-DMAC7.html)
JP (1) JP6073888B2 (cg-RX-API-DMAC7.html)
CN (2) CN103998470A (cg-RX-API-DMAC7.html)
AU (1) AU2012296588B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014008680A2 (cg-RX-API-DMAC7.html)
CA (1) CA2849015C (cg-RX-API-DMAC7.html)
DK (1) DK2744831T3 (cg-RX-API-DMAC7.html)
ES (1) ES2659161T3 (cg-RX-API-DMAC7.html)
NO (1) NO2820418T3 (cg-RX-API-DMAC7.html)
PL (1) PL2744831T3 (cg-RX-API-DMAC7.html)
PT (1) PT2744831T (cg-RX-API-DMAC7.html)
SI (1) SI2744831T1 (cg-RX-API-DMAC7.html)
TR (1) TR201802686T4 (cg-RX-API-DMAC7.html)
WO (1) WO2013025846A2 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014180288A1 (zh) * 2013-05-06 2014-11-13 中国药科大学 具有抑制肿瘤微环境血管再生和激活适应性免疫应答双功能的融合蛋白及其基因和应用
WO2014203182A1 (en) * 2013-06-20 2014-12-24 Novartis Ag Use of a vegf antagonist in treating choroidal neovascularisation
US11058750B2 (en) 2015-12-03 2021-07-13 Mor Research Applications Ltd. Compositions and methods for treatment of ocular diseases
KR101818151B1 (ko) 2016-03-25 2018-01-16 한국과학기술원 트렌스페린을 포함하는 허혈성망막병증 예방 및 치료용 조성물
CN109053899B (zh) * 2017-12-22 2021-11-16 湖南远泰生物技术有限公司 一种含人转铁蛋白抗原表位序列的嵌合体抗原受体

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672683A (en) 1989-09-07 1997-09-30 Alkermes, Inc. Transferrin neuropharmaceutical agent fusion protein
US20050192242A1 (en) 1995-10-11 2005-09-01 Neal Zane C. Therapeutic fusion protein transgenes
CA2331332A1 (en) * 1998-06-17 1999-12-23 Raghuram Kalluri Anti-angiogenic proteins and methods of use thereof
JP2003517847A (ja) 1999-12-23 2003-06-03 ヒューマン ジノーム サイエンシーズ, インコーポレイテッド トランスフェリンポリヌクレオチド、ポリペプチド、および抗体
WO2003020746A1 (en) 2001-08-30 2003-03-13 Biorexis Pharmaceutical Corporation Modified transferrin fusion proteins
US8129504B2 (en) * 2001-08-30 2012-03-06 Biorexis Technology, Inc. Oral delivery of modified transferrin fusion proteins
EP2261250B1 (en) 2001-12-21 2015-07-01 Human Genome Sciences, Inc. GCSF-Albumin fusion proteins
NZ534310A (en) * 2002-02-07 2008-03-28 Novozymes Delta Ltd Albumin-fused anti-angiogenesis peptides
EP1670428A4 (en) 2003-10-10 2008-03-12 Univ Southern California HYBRID PROTEINS G-CSF-TRANSFERRIN
EP1722762A2 (en) * 2004-03-02 2006-11-22 Massachusetts Institute of Technology Nanocell drug delivery system
WO2006044614A2 (en) 2004-10-14 2006-04-27 Sopherion Therapeutics, Inc. Anti-angiogenic peptides and methods of use thereof
WO2006049983A2 (en) 2004-10-27 2006-05-11 Biorexis Pharmaceutical Corporation Peptide yy modified transferrin fusion proteins
WO2006119128A2 (en) * 2005-04-29 2006-11-09 Research Development Foundation Vascular targeting of ocular neovascularization
EP2468294A1 (en) 2006-02-03 2012-06-27 Crc For Asthma And Airways Ltd A method of modulating cellular activity and agents for use therein
CN101070349B (zh) * 2007-05-22 2010-10-13 山西康宝生物制品股份有限公司 具有选择性杀伤肿瘤新生血管内皮细胞作用的融合蛋白与应用
CN101092452A (zh) * 2007-05-23 2007-12-26 哈尔滨医科大学 肿瘤抑素抗血管生成小分子多肽、融合蛋白及两者制备方法
WO2009086132A2 (en) * 2007-12-20 2009-07-09 University Of Southern California Design of spacers to increase the expression of recombinant fusion proteins
JP6101638B2 (ja) 2011-03-03 2017-03-22 ザイムワークス,インコーポレイテッド 多価ヘテロマルチマー足場設計及び構築物

Also Published As

Publication number Publication date
WO2013025846A2 (en) 2013-02-21
TR201802686T4 (tr) 2018-03-21
JP2014526890A (ja) 2014-10-09
CA2849015C (en) 2017-08-08
EP2744831A2 (en) 2014-06-25
PL2744831T3 (pl) 2018-05-30
JP6073888B2 (ja) 2017-02-01
SI2744831T1 (en) 2018-04-30
US9290562B2 (en) 2016-03-22
PT2744831T (pt) 2018-03-05
DK2744831T3 (en) 2018-03-05
US20140179612A1 (en) 2014-06-26
AU2012296588B2 (en) 2017-07-27
AU2012296588A1 (en) 2014-04-03
CA2849015A1 (en) 2013-02-21
CN103998470A (zh) 2014-08-20
EP2744831A4 (en) 2015-03-11
EP2744831B1 (en) 2017-12-06
BR112014008680A2 (pt) 2017-06-13
ES2659161T3 (es) 2018-03-14
CN110105453A (zh) 2019-08-09
WO2013025846A3 (en) 2013-05-02

Similar Documents

Publication Publication Date Title
BR112013022641A2 (cg-RX-API-DMAC7.html)
BR112013031251A2 (cg-RX-API-DMAC7.html)
BR112013027245A2 (cg-RX-API-DMAC7.html)
BR112013024383A2 (cg-RX-API-DMAC7.html)
BR112013023185A2 (cg-RX-API-DMAC7.html)
BR112013026905A2 (cg-RX-API-DMAC7.html)
BR112013022995A2 (cg-RX-API-DMAC7.html)
BR112013027830A2 (cg-RX-API-DMAC7.html)
BR112013026744A2 (cg-RX-API-DMAC7.html)
BR112013023927A2 (cg-RX-API-DMAC7.html)
BR112013027452A2 (cg-RX-API-DMAC7.html)
BR112013024365A2 (cg-RX-API-DMAC7.html)
BR112013028733A2 (cg-RX-API-DMAC7.html)
BR112013027121A2 (cg-RX-API-DMAC7.html)
BR112013024588A2 (cg-RX-API-DMAC7.html)
BR112013031556A2 (cg-RX-API-DMAC7.html)
BR112013026790A2 (cg-RX-API-DMAC7.html)
BR112013032366A2 (cg-RX-API-DMAC7.html)
BR112013032377A2 (cg-RX-API-DMAC7.html)
BR112013032380A2 (cg-RX-API-DMAC7.html)
BR112013027836A2 (cg-RX-API-DMAC7.html)
BR112013026895A2 (cg-RX-API-DMAC7.html)
BR112013027761A2 (cg-RX-API-DMAC7.html)
BR112013021637A2 (cg-RX-API-DMAC7.html)
BR112013023266A2 (cg-RX-API-DMAC7.html)